Resources
Advanced Search
Start Free Trial
Talk With Sales
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ImmunoGen
Growth Score
26
CB Rank
90924
Heat Score
41
Save
Actions
ImmunoGen engages in the research and development of antibody-based anticancer therapeutics using its targeted antibody payload technology.
Acquired by
AbbVie
Founded
obfuscated
obfuscation
Public
Post-IPO Equity
Waltham
,
Massachusetts
,
United States
501-1000
www.immunogen.com
Biotechnology
Health Care
Medical
Therapeutics
ImmunoGen
Section: People
Actions